77.68 F
October 3, 2023
Image default
Business Culture

Pfizer says its COVID-19 vaccine is over 90 percent effective

Pfizer has been working with BioNTech on a vaccine for COVID-19, and their early analysis suggests their vaccine candidate is over 90% effective. That would be a much higher than expected rate of efficacy from one of the earliest vaccine candidates for the virus. The U.S. Food and Drug Administration is looking for at least 50% efficacy from a COVID-19 vaccine.Q3 2020 hedge fund letters, conferences and morePfizer vaccine may be very effectiveThe interim analysis focused on the first 94 confirmed cases of COVID-19 among the over 43,000 volunteers who received either two doses of the vaccine or…

Read More

Related posts

‘Diablo Immortal’ and the Truth About Free-to-Play Mobile Games


Pac-12 football preview: Ranking the most impactful newcomers of 2020


Here’s Where Americans Are Spending Their Money


Delta variant, shortages severely restrict U.S. economic growth in third quarter


Unfazed by pandemic, supply chain woes, Santa Claus readies for annual flight


Uber sees $1.8 bn loss as pandemic stalls revenue


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: